Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
Sagimet Biosciences Inc. - Series A shareholders
As of Jun 30, 2026, 119 institutions reported holding Sagimet Biosciences Inc. - Series A, 71.9% of its shares. Largest: BlackRock, Balyasny Asset Management L.P. and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Sagimet Biosciences Inc. - Series A | Change | Filed |
|---|---|---|---|---|
| BlackRock | 6.58M | 9.3% | +5.78M | Aug 7, 2026 |
| Balyasny Asset Management L.P. | 3.63M | 5.1% | new | Aug 14, 2026 |
| Vanguard | 3.39M | 4.8% | +2.12M | Aug 13, 2026 |
| Woodline Partners LP | 3M | 4.2% | +2M | Aug 14, 2026 |
| Silverarc Capital Management, LLC | 2.93M | 4.1% | new | Aug 13, 2026 |
| Caligan Partners LP | 2.5M | 3.5% | new | Aug 14, 2026 |
| Bvf Inc | 2.5M | 3.5% | new | Aug 14, 2026 |
| Affinity Asset Advisors, LLC | 2.5M | 3.5% | +1.63M | Aug 13, 2026 |
| Federated Hermes, Inc. | 2.09M | 2.9% | +2.09M | Aug 12, 2026 |
| Great Point Partners LLC | 2.03M | 2.9% | new | Aug 14, 2026 |